Helicobacter pylori infection induces gastric cancer cell malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis

Alipour M (2021) Molecular mechanism of Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer 52:23–30

Article  CAS  PubMed  Google Scholar 

Amieva M, Peek RM Jr (2016) Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology 150:64–78

Article  CAS  PubMed  Google Scholar 

Bai Y, Long J, Liu Z, Lin J, Huang H, Wang D, Yang X, Miao F, Mao Y, Sang X et al (2019) Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression. J Cell Physiol 234:18837–18848

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965–3981

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bridges MC, Daulagala AC, Kourtidis A (2021) LNCcation: lncRNA localization and function. J Cell Biol 220:e202009045

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, He P (2021) Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis. J Pharm Pharmacol 73:1387–1396

Article  PubMed  Google Scholar 

Deng Y, Ding X, Song Q, Zhao G, Han L, Ding B, Wang X, Hao X, Li H (2021) Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer. Cell Oncol (Dordr) 44:701–714

Article  CAS  PubMed  Google Scholar 

Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379

Article  CAS  PubMed  Google Scholar 

Hu J, Wang M, Yang Y, Xing Y, Li S (2022a) LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway. Immunopharmacol Immunotoxicol 44:719–731

Article  CAS  PubMed  Google Scholar 

Hu S, Song Y, Zhou Y, Jiao Y, Wang S (2022b) MiR-1270 suppresses the malignant progression of breast cancer via targeting MMD2. J Healthc Eng 2022:3677720

Article  PubMed  PubMed Central  Google Scholar 

Iyer DN, Foo DC, Lo OS, Wan TM, Li X, Sin RW, Pang RW, Law WL, Ng L (2022) MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer. BMC Cancer 22:351

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Y, Zhang X, Rong L, Hou Y, Song J, Zhang W, He M, Xie Y, Li Y, Song F (2021) Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network. Oncol Lett 21:456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu G, Liu B, Liu X, Xie L, He J, Zhang J, Dong R, Ma D, Dong K, Ye M (2021) ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3. J Cell Mol Med 25:3524–3536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Zheng S, Wu Q, Wu J, Zhou R, Wang C, Wu Z, Rong X, Huang N, Sun L et al (2021) Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy 17:4083–4101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W (2015) ceRNA in cancer: possible functions and clinical implications. J Med Genet 52:710–718

Article  PubMed  Google Scholar 

Rajabi A, Riahi A, Shirabadi-Arani H, Moaddab Y, Haghi M, Safaralizadeh R (2022) Overexpression of HOXA-AS2 LncRNA in patients with gastric cancer and its association with Helicobacter pylori infection. J Gastrointest Cancer 53:72–77

Article  CAS  PubMed  Google Scholar 

Shou J, Gao H, Cheng S, Wang B, Guan H (2021) LncRNA HOXA-AS2 promotes glioblastoma carcinogenesis by targeting miR-885-5p/RBBP4 axis. Cancer Cell Int 21:39

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33

Article  PubMed  Google Scholar 

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396:635–648

Article  CAS  PubMed  Google Scholar 

Song Z, Zou S, Zhou W, Huang Y, Shao L, Yuan J, Gou X, Jin W, Wang Z, Chen X et al (2020) Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning. Nat Commun 11:4294

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun J, Li J, Zhang W, Zhang J, Sun S, Li G, Song H, Wan D (2017) MicroRNA-509-3p inhibits cancer cell proliferation and migration via upregulation of XIAP in gastric cancer cells. Oncol Res 25:455–461

Article  PubMed  PubMed Central  Google Scholar 

Thrift AP, El-Serag HB (2020) Burden of gastric cancer. Clin Gastroenterol Hepatol 18:534–542

Article  PubMed  Google Scholar 

Wang N, Mei Q, Wang Z, Zhao L, Zhang D, Liao D, Zuo J, Xie H, Jia Y, Kong F (2022) Research progress of antibody–drug conjugate therapy for advanced gastric cancer. Front Oncol 12:889017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei GH, Wang X (2017) lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci 21:3850–3856

PubMed  Google Scholar 

Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M (2020) Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer 19:62

Article  PubMed  PubMed Central  Google Scholar 

Wu Q, Lu S, Zhang L, Zhao L (2021) LncRNA HOXA-AS2 activates the notch pathway to promote cervical cancer cell proliferation and migration. Reprod Sci 28:3000–3009

Article  CAS  PubMed  Google Scholar 

Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135:584–590

Article  PubMed  Google Scholar 

Xiang L, Lan C (2022) Significance of a tumor mutation burden gene signature with prognosis and immune feature of gastric cancer patients. Int J Genomics 2022:7684606

Article  PubMed  PubMed Central  Google Scholar 

Xiao S, Song B (2020) LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis. Biosci Rep 40:BSR20193287

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Chen W, Wang Y, Zhang Y, Xia R, Shen J, Gong X, Liang Y, Xu J, Tang H et al (2022) N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. BMC Cancer 22:721

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Xu J, Zhang S, An J, Zhang J, Huang J, Jin Y (2018) HOXA-AS2 promotes proliferation and induces epithelial–mesenchymal transition via the miR-520c-3p/GPC3 axis in hepatocellular carcinoma. Cell Physiol Biochem 50:2124–2138

Article  CAS  PubMed  Google Scholar 

Zhang H, Liu S, Chen L, Sheng Y, Luo W, Zhao G (2021) MicroRNA miR-509-3p inhibit metastasis and epithelial–mesenchymal transition in hepatocellular carcinoma. Bioengineered 12:2263–2273

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Z, Xing Y, Yang F, Zhao Z, Shen Y, Song J, Jing S (2021) LncRNA HOXA-AS2 promotes oral squamous cell proliferation, migration, and invasion via upregulating EZH2 as an oncogene. Technol Cancer Res Treat 20:15330338211039108

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif